Literature DB >> 34893339

Eliminating the buprenorphine DEA X waiver is critical to promote health equity.

Katie Fitzgerald Jones1, Monica O'Reilly-Jacob2, Mathew Tierney3.   

Abstract

Entities:  

Keywords:  Buprenorphine; DEA X waiver; Health equity; Opioid use disorder

Mesh：

Substances：

Year:  2021        PMID： 34893339      PMCID： PMC8821122          DOI： 10.1016/j.outlook.2021.10.003

Source DB:  PubMed          Journal:  Nurs Outlook        ISSN： 0029-6554            Impact factor:   3.250


× No keyword cloud information.
  6 in total

1.  Buprenorphine Treatment Divide by Race/Ethnicity and Payment.

Authors:  Pooja A Lagisetty; Ryan Ross; Amy Bohnert; Michael Clay; Donovan T Maust
Journal:  JAMA Psychiatry       Date:  2019-09-01       Impact factor: 21.596

2.  Expanding access to nurse-managed medication for opioid use disorder.

Authors:  Travis A Cos; Laura E Starbird; Heeyoung Lee; Bianca Chun; Kristine Gonnella; Jillian Bird; Kae Livsey; Shelley Bastos; Marie O'Brien; Ivy Clark; Darlene Jenkins; Laureen Tavolaro-Ryley
Journal:  Nurs Outlook       Date:  2021-05-12       Impact factor: 3.250

3.  Is the Prescription Opioid Epidemic a White Problem?

Authors:  Helena Hansen; Julie Netherland
Journal:  Am J Public Health       Date:  2016-12       Impact factor: 9.308

4.  Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver.

Authors:  Kevin Fiscella; Sarah E Wakeman; Leo Beletsky
Journal:  JAMA Psychiatry       Date:  2019-03-01       Impact factor: 21.596

5.  Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018-2019, From the HEALing Communities Study.

Authors:  Marc R Larochelle; Svetla Slavova; Elisabeth D Root; Daniel J Feaster; Patrick J Ward; Sabrina C Selk; Charles Knott; Jennifer Villani; Jeffrey H Samet
Journal:  Am J Public Health       Date:  2021-09-09       Impact factor: 11.561

6.  Medicaid Expansion Increased Medications For Opioid Use Disorder Among Adults Referred By Criminal Justice Agencies.

Authors:  Utsha G Khatri; Benjamin A Howell; Tyler N A Winkelman
Journal:  Health Aff (Millwood)       Date:  2021-04       Impact factor: 6.301
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.